Smith & Nephew PLC
Lezárt
1,020
Áttekintés
Árfolyamváltozás megosztása
24 óra
Minimum
1016
Maximum
1039
Bevétel | -42M 301M |
|---|---|
Értékesítés | -234M 3.1B |
P/E Szektor átlag | 19.824 32.138 |
Osztalékhozam | 3.73 |
Profit margin | 9.784 |
Munkavállalók | 17,000 |
EBITDA | -113M 773M |
Osztalékhozam Szektor átlag | 3.73% 3.59% |
|---|---|
Következő osztalékfizetési dátum | 2026. nov. 6. |
Következő korábbi osztalék dátum | 2026. okt. 1. |
Piaci kapitalizáció | -390M 9B |
|---|---|
Előző nyitás | 1020 |
Előző zárás | 1020 |
Smith & Nephew PLC Chart
A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.
Kapcsolódó hírek
Társak összehasonlítása
Árváltozás
Smith & Nephew PLC Előrejelzés
Pénzügyek
Értékesítési és adminisztrációs költségek
Üzemeltetési költségek
Adózás előtti nyereség
Értékesítés
Értékesítési költség
Értékesítési bruttó nyereség
Kamatköltség a hitelre
EBITDA
Üzemi nyereség
$
Rólunk Smith & Nephew PLC
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
